Financing and Delivering Pre-Exposure Prophylaxis (PrEP) to End the HIV Epidemic

作者：Amy Killelea, Jeremiah Johnson, Derek T. Dangerfield, Chris Beyrer, Matthew McGough, John A. McIntyre, Rebekah E. Gee, Jeromie Ballreich, Rena M. Conti, Tim Horn, Jim Pickett, Joshua M. Sharfstein · 发表于：The Journal of Law Medicine & Ethics · 年份：2022 · DOI：10.1017/jme.2022.30 · 被引用次数：44 · 研究领域：HIV/AIDS Research and Interventions、HIV, Drug Use, Sexual Risk、Sex work and related issues

The U.S. has the tools to end the HIV epidemic, but progress has stagnated. A major gap in U.S. efforts to address HIV is the under-utilization of medications that can virtually eliminate acquisition of the virus, known as pre-exposure prophylaxis (PrEP). This document proposes a financing and delivery system to unlock broad access to PrEP for those most vulnerable to HIV acquisition and bring an end to the HIV epidemic.